Predict your next investment

Corporation
HEALTHCARE | Drug Discovery

See what CB Insights has to offer

Investors Count

1

Neopharmed Gentili Funding, Neopharmed Gentili Valuation & Neopharmed Gentili Revenue

1 Fundings

Neopharmed Gentili's latest funding round was a Acq - Fin for on November 28, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/28/2018

Acq - Fin

$0.00B

((9.99x))

FY 1234

2

Date

11/28/2018

Round

Acq - Fin

Amount

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

Sources

2

Neopharmed Gentili Investors

1 Investors

Neopharmed Gentili has 1 investors. Ardian invested in Neopharmed Gentili's Acq - Fin funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/28/2018

11/28/2018

1
Acq - Fin

Private Equity

France

First funding

11/28/2018

Last Funding

11/28/2018

Investor

Rounds

1
Acq - Fin

Board Seats

Type

Private Equity

Location

France

Neopharmed Gentili Acquisitions

1 Acquisition

Neopharmed Gentili acquired 1 company. Their latest acquisition was MDM on October 31, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/31/2019

Acquired

1

Date

10/31/2019

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.